Sign In

Vanessa Almendro, PhD, MBA 🟦

Vice President, Science and Technology. Head of Innovation at Danaher Corporation

Vanessa Almendro, PhD, MBA, is a prominent figure in the field of science and technology, currently serving as the Vice President of Science and Technology at Danaher Corporation. She has extensive experience in translational research and drug development, spanning over 18 years across various disease areas, including cancer.12

Education and Background

  • PhD from the University of Barcelona
  • Post-doctoral training at Dana-Farber Cancer Institute and Harvard Medical School
  • Executive MBA from MIT Sloan School of Management

Roles and Contributions

In addition to her position at Danaher, Almendro is a board member of the MIT Sandbox Innovation Fund Program, where she contributes to fostering innovation and entrepreneurship among students. She is also a Senior Principal and Co-Founder of the Brain Tumor Investment Fund, which aims to catalyze private sector investment in brain tumor research and treatment.13

Almendro's leadership extends to various initiatives aimed at bridging the gap between scientific research and practical applications in healthcare. Her work emphasizes the importance of innovative solutions in addressing complex health challenges.

Professional Affiliations

  • Board member at MIT Sandbox Innovation Fund Program
  • Senior Principal at Brain Tumor Investment Fund
  • Vice President at Danaher Corporation

Her multifaceted career reflects a commitment to advancing medical science through strategic leadership and innovation.

Highlights

Aug 18 · linkedin

Dear colleagues, join us in Boston for Integrated DNA Technologies’ first Synthetic Biology Leadership Seminar.

Together with my colleagues Sadik Kassim and Sandy Ottensmann, and with keynote presentations from Sangeeta Bhatia, Dan Anderson, Pamela Silver and Ron Weiss the event will review advances in synthetic biology and biological engineering for the development of novel therapies. Themes for discussion will include translational genomics, therapeutic protein engineering, diagnostics via nanotechnology, and biosensors and biocircuits.

Attendance is free, space is limited. Find speaker and registration information here:

https://lnkd.in/eAPDmvbp

#IDTsynbio #syntheticbiology #synbio

Aug 14 · linkedin

The groundbreaking work by Carl June and the University of Pennsylvania investigators in the fight against #braincancer brings hope, but it also reminds us how much more we need to do. As incredible as these advancements are, the battle against brain cancer is far from over. With more than 1 million people living with brain cancer in the US today we must continue to support cutting-edge research like this and provide the necessary funding to turn these breakthroughs into lasting solutions.

I am honored to be member and supporter of the National Brain Tumor Society and the Brain Tumor Investment Fund, great philanthropic organizations lead by David Arons and John Higgins, respectively, supporting advocacy, research, and investment efforts against brain cancer.

Related Questions

What are Vanessa Almendro's main responsibilities at Danaher Corporation?
How has Vanessa Almendro contributed to the Brain Tumor Investment Fund?
What is Vanessa Almendro's educational background?
What are some of Vanessa Almendro's notable achievements in the field of cancer research?
How did Vanessa Almendro transition from academia to industry?
Vanessa Almendro, PhD, MBA 🟦
Vanessa Almendro, PhD, MBA 🟦, photo 1
Vanessa Almendro, PhD, MBA 🟦, photo 2
Add to my network

Experience

Vice President, Science and Technology, Head of Innovation at Danaher Corporation (June 2021 - Present)
Managing Partner and co-founder National Brain Tumor Society Investment Fund at National Brain Tumor Society (October 2019 - Present); Head of Strategy and External Innovation at Eisai Center for Gene at Vertex Pharmaceuticals (2014 - October 2016)

Education

Bachelor in Biology from University of Barcelona (1996-2000); Ph.D. in Biochemistry and Molecular Biology, Summa cum laude from University of Barcelona (2000-2004); Post-doctoral training from Harvard

Location

Brookline, Massachusetts, United States